B. Meyers

G. Papanicolaou, B. Meyers, F. Borrego, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Sensitive indicators of inorganic mercury toxicity.

B. Meyers, K. Rosenman, J. Valciukas, 1986, Archives of environmental health.

Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers

B. Meyers, S. Hirschman, E. Srulevitch, 1983, Antimicrobial Agents and Chemotherapy.

Clinical Pharmacokinetics of Antibacterial Drugs in the Elderly

B. Meyers, P. Wilkinson, 1989, Clinical pharmacokinetics.

Infectious ocular complications in orthotopic liver transplant patients.

G. Papanicolaou, B. Meyers, S. Emre, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculosis in liver transplant patients.

B. Meyers, P. Sheiner, C. Miller, 1994, Transplantation.

Neurotoxicity of Local Anesthetics

B. Meyers, M. Kalichman, H. Powell, 1986 .

Patient survival factors in paranasal sinus mucormycosis

A. Blitzer, W. Lawson, H. Biller, 1980, The Laryngoscope.

Malignant external otitis. Comparison of monotherapy vs combination therapy.

B. Meyers, S. Hirschman, M. Mendelson, 1987, Archives of otolaryngology--head & neck surgery.

Treatment of invasive external otitis with cefsulodin.

B. Meyers, S. Hirschman, M. Mendelson, 1984, Reviews of infectious diseases.

Bacterial resistance: exploring the facts and myths.

B. Meyers, 1987, Bulletin of the New York Academy of Medicine.

Candida endophthalmitis complicating candidemia.

B. Meyers, A. P. Ferry, T. Lieberman, 1973, Annals of internal medicine.

Rhinocerebral mucormycosis: premortem diagnosis and therapy.

A. Blitzer, B. Meyers, S. Hirschman, 1979, Archives of internal medicine.

Pharmacokinetic Study of Netilmicin

B. Meyers, S. Hirschman, G. Wormser, 1977, Antimicrobial Agents and Chemotherapy.

Comparative toxicities of third-generation cephalosporins.

B. Meyers, Burt R. Meyers, 1985, The American journal of medicine.

Pseudomonas aeruginosa bacteremia in patients with AIDS.

A. Gurtman, B. Meyers, S. Hirschman, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis

B. Meyers, S. Hirschman, E. Srulevitch, 1981, Antimicrobial Agents and Chemotherapy.

Infections caused by microorganisms of the genus Erwinia.

B. Meyers, S. Hirschman, E. Bottone, 1972, Annals of internal medicine.

Pharmacology of cefazolin in human volunteers.

P. Nicholas, B. Meyers, S. Hirschman, 1973, Journal of clinical pharmacology.

Infectious disease management with oral antibiotics

B. Meyers, Dr. B. R. Meyers, 2005, Infection.

Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside.

B. Meyers, S. Hirschman, 1972, The Journal of clinical pharmacology and new drugs.

Tuberculosis in liver transplant patients.

B. Meyers, P. Sheiner, C. Miller, 1994, Transplantation.

Comparison of the Antibacterial Activities of Sisomicin and Gentamicin Against Gram-Negative Bacteria

B. Meyers, S. Hirschman, B. Leng, 1975, Antimicrobial Agents and Chemotherapy.

Concentration of Clindamycin in Human Bone

B. Meyers, S. Hirschman, P. Nicholas, 1975, Antimicrobial Agents and Chemotherapy.

Pharmacologic studies on tobramycin and comparison with gentamicin.

B. Meyers, S. Hirschman, 1972, The Journal of clinical pharmacology and new drugs.

Mycobacterium tuberculosis infection in solid organ transplant recipients.

B. Meyers, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intracranial Tuberculoma in a Liver Transplant Patient: First Reported Case and Review of the Literature

B. Meyers, C. Henderson, B. Liu, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antibacterial activity of cefamandole in vitro.

B. Meyers, S. Hirschman, 1978, The Journal of infectious diseases.

Antimicrobial Activity of Cefamandole Against Salmonella typhi

B. Meyers, S. Hirschman, Albert G. Miller, 1977, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Cefamandole in Patients with Renal Failure

B. Meyers, S. Hirschman, 1977, Antimicrobial Agents and Chemotherapy.

Pharmacological Studies with Cefamandole in Human Volunteers

B. Meyers, S. Hirschman, B. Ribner, 1976, Antimicrobial Agents and Chemotherapy.

Cefamandole: Antimicrobial Activity In Vitro of a New Cephalosporin

B. Meyers, S. Hirschman, B. Leng, 1975, Antimicrobial Agents and Chemotherapy.

Cephalexin: Microbiological effects and pharmacologic parameters in man

B. Meyers, L. Weinstein, K. Kaplan, 1969, Clinical pharmacology and therapeutics.

Pulmonary toxoplasmosis in AIDS.

B. Meyers, S. Hirschman, L. Finkel, 1987, Scandinavian journal of infectious diseases.

Mycotic aneurysm of the ascending aorta secondary to Serratia infection: differentiation from prosthetic valve endocarditis.

B. Meyers, M. Lefkowitz, R. Shah, 1974, Chest.

Cephanone: In Vitro Antibacterial Activity and Pharmacology in Normal Human Volunteers

B. Meyers, S. Hirschman, P. Nicholas, 1972, Antimicrobial Agents and Chemotherapy.

Cephapirin: In Vitro Antibacterial Spectrum

B. Meyers, S. Hirschman, J. Axelrod, 1971 .

Cephapirin: in vitro antibacterial spectrum.

B. Meyers, S. Hirschman, J. Axelrod, 1971, Applied microbiology.

Pharmacologic Studies with Cefaclor, a New Oral Cephalosporin

B. Meyers, S. Hirschman, G. Wormser, 1978, Journal of clinical pharmacology.

Cephapirin: pharmacology in normal human volunteers.

B. Meyers, S. Hirschman, J. Axelrod, 1972, The Journal of clinical pharmacology and new drugs.

Antimicrobial Activity in Vitro of Cefaclor, A New Oral Cephalosporin

B. Meyers, SHALOM Z. HIRSCHMAN, 1978, Journal of clinical pharmacology.

Generalized Shwartzman reaction in man after a dog bite. Consumption coagulopathy, symmetrical peripheral gangrene, and renal cortical necrosis.

B. Meyers, S. Hirschman, W. Sloan, 1970, Annals of internal medicine.

A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

Jerome J. Schentag, G. Bernard, R. Greenman, 1991 .

EFFICACY OF OFLOXACIN FOR THE TREATMENT OF PNEUMONIA, SKIN AND SKIN STRUCTURE INFECTION, AND URINARY TRACT INFECTION IN AN ELDERLY POPULATION

A. Elixhauser, D. Revicki, L. Nicolle, 1993 .

Comparison of Activity of Sisomicin and Gentamicin in Mouse Protection Tests with Gram-Negative Bacilli

B. Meyers, S. Hirschman, Shalom Z. Hirschman, 1976, Antimicrobial Agents and Chemotherapy.

Bacteriological, pharmacological, and clinical studies of carbenicillin.

B. Meyers, J. Sabbaj, L. Weinstein, 1970, Archives of internal medicine.

Ludwig's angina. Case report, with review of bacteriology and current therapy.

B. Meyers, S. Hirschman, W. Lawson, 1972, The American journal of medicine.

Study of a Needleless Intermittent Intravenous-Access System for Peripheral Infusions: Analysis of Staff, Patient, and Institutional Outcomes

B. Meyers, S. Hirschman, C. Schechter, 1998, Infection Control & Hospital Epidemiology.

Treating community-acquired lower respiratory infection.

B. Meyers, 1983, American family physician.

Microbiological and Pharmacological Behavior of 7-Chlorolincomycin

B. Meyers, L. Weinstein, K. Kaplan, 1969 .

Microbiological and pharmacological behavior of 7-chlorolincomycin.

B. Meyers, L. Weinstein, K. Kaplan, 1969, Applied microbiology.

High‐dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation

Charles M. Miller, B. Meyers, M. Schwartz, 1995 .

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation

B. Meyers, M. Schwartz, S. Emre, 1995, Transplant international : official journal of the European Society for Organ Transplantation.

Cefaclor revisited.

B. Meyers, 2000, Clinical Therapeutics.

Infection due to Actinobacillus actinomycetemcomitans.

B. Meyers, S. Hirschman, E. Bottone, 1971, American journal of clinical pathology.

Isoniazid hepatotoxicity after orthotopic liver transplantation.

B. Meyers, I. Fiel, J. Guarrera, 1996, The Mount Sinai journal of medicine, New York.

Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation.

B. Meyers, M. Schwartz, P. Sheiner, 1994, Transplantation.

Prophylactic antibiotics in neurosurgery.

B. Meyers, L. Malis, M. Savitz, 1974, Surgical neurology.

In vitro studies of the activity of coumermycin-A1 against staphylococci resistant to methicillin and cephalothin.

B. Meyers, D. Michaeli, L. Weinstein, 1969, The Journal of infectious diseases.

Clinical experience with cefotaxime in the treatment of patients with bacteremia.

B. Meyers, 1982, Reviews of infectious diseases.

Biliary concentrations of piperacillin in patients undergoing cholecystectomy

B. Meyers, S. Hirschman, J. Girón, 1981, Antimicrobial Agents and Chemotherapy.

Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant.

B. Meyers, M. Schwartz, S. Emre, 1999, The Mount Sinai journal of medicine, New York.

Ofloxacin use in a geriatric population.

L. Nicolle, B. Meyers, P. Alessi, 1991, Chemotherapy.

Serious infections in the elderly.

B. Meyers, 1987, The Mount Sinai journal of medicine, New York.

Prophylaxis with cephalothin in peritoneal dialysis.

B. Meyers, S. Hirschman, J. Axelrod, 1973, Archives of Internal Medicine.

Study of a Needleless Intermittent Intravenous-Access System for Peripheral Infusions: Analysis of Staff, Patient, and Institutional Outcomes

B. Meyers, S. Hirschman, C. Schechter, 1998, Infection Control & Hospital Epidemiology.

Pharmacokinetic Properties of Mezlocillin in Ambulatory Elderly Subjects

B. Meyers, S. Hirschman, M. Mendelson, 1987, Journal of clinical pharmacology.